Literature DB >> 17318452

Psychological follow-up of presymptomatic genetic testing for spinocerebellar ataxia type 2 (SCA2) in Cuba.

Milena Paneque1, Carolina Lemos, Karell Escalona, Lizandra Prieto, Rubén Reynaldo, Mercedes Velázquez, Judith Quevedo, Nieves Santos, Luis Enrique Almaguer, Luis Velázquez, Alda Sousa, Manuela Fleming, Jorge Sequeiros.   

Abstract

Presymptomatic testing for spinocerebellar ataxia type 2 (SCA2) in Cuba started five years ago. We have now investigated the psychological impact of test results on 150 individuals at 50% risk for SCA2. In a prospective study, psychological instruments were used to evaluate depression, anxiety and family functioning (1) before testing and (2) one year after disclosure of the test result. One year after, anxiety and depression levels decreased both in carriers and non-carriers, but anxiety decreased significantly more in carriers. Pathological levels of anxiety were seen mostly in members of dysfunctional families, but decreased more in them than in other consultands. Presymptomatic testing thus seems to have been especially beneficial for these testees, possibly due to a greater gain from the psychosocial support received. It would be pertinent to evaluate now the impact of other psychosocial variables and perform longer-term longitudinal studies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17318452     DOI: 10.1007/s10897-006-9083-y

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  39 in total

1.  [Results of a program of presymptomatic diagnosis of Huntington's disease: evaluation of a 6 year period].

Authors:  M P Solís-Pérez; J A Burguera; F Palau; L Livianos; M Vila; L Rojo
Journal:  Neurologia       Date:  2001-10       Impact factor: 3.109

2.  Psychological studies in Huntington's disease: making up the balance.

Authors:  M Duisterhof; R W Trijsburg; M F Niermeijer; R A Roos; A Tibben
Journal:  J Med Genet       Date:  2001-12       Impact factor: 6.318

3.  Autosomal dominant cerebellar ataxia: clinical analysis of 263 patients from a homogeneous population in Holguín, Cuba.

Authors:  G Orozco Diaz; A Nodarse Fleites; R Cordovés Sagaz; G Auburger
Journal:  Neurology       Date:  1990-09       Impact factor: 9.910

Review 4.  Predictive testing for Huntington disease: a psychologist's view.

Authors:  S Kessler
Journal:  Am J Med Genet       Date:  1994-09-15

5.  Predictors of psychological adjustment to genetic testing for Huntington's disease.

Authors:  A M Codori; P R Slavney; C Young; D L Miglioretti; J Brandt
Journal:  Health Psychol       Date:  1997-01       Impact factor: 4.267

Review 6.  Psychological consequences of predictive genetic testing: a systematic review.

Authors:  M Broadstock; S Michie; T Marteau
Journal:  Eur J Hum Genet       Date:  2000-10       Impact factor: 4.246

7.  A hereditary disorder in the family and the family life cycle: Huntington disease as a paradigm.

Authors:  A Christine Brouwer-Dudokdewit; Anke Savenije; Moniek W Zoeteweij; Anneke Maat-Kievit; Aad Tibben
Journal:  Fam Process       Date:  2002

8.  Predictive testing for Huntington disease in Canada: adverse effects and unexpected results in those receiving a decreased risk.

Authors:  M Huggins; M Bloch; S Wiggins; S Adam; O Suchowersky; M Trew; M Klimek; C R Greenberg; M Eleff; L P Thompson
Journal:  Am J Med Genet       Date:  1992-02-15

9.  Ethical and social issues in presymptomatic testing for Huntington's disease: a European Community collaborative study. European Community Huntington's Disease Collaborative Study Group.

Authors: 
Journal:  J Med Genet       Date:  1993-12       Impact factor: 6.318

10.  Presymptomatic diagnosis of delayed-onset disease with linked DNA markers. The experience in Huntington's disease.

Authors:  J Brandt; K A Quaid; S E Folstein; P Garber; N E Maestri; M H Abbott; P R Slavney; M L Franz; L Kasch; H H Kazazian
Journal:  JAMA       Date:  1989-06-02       Impact factor: 56.272

View more
  8 in total

1.  Ethical dilemmas in genetic testing: examples from the Cuban program for predictive diagnosis of hereditary ataxias.

Authors:  Tania Cruz Mariño; Rubén Reynaldo Armiñán; Humberto Jorge Cedeño; José Miguel Laffita Mesa; Yanetza González Zaldivar; Raúl Aguilera Rodríguez; Miguel Velázquez Santos; Luis Enrique Almaguer Mederos; Milena Paneque Herrera; Luis Velázquez Pérez
Journal:  J Genet Couns       Date:  2011-01-25       Impact factor: 2.537

2.  Presymptomatic testing for neurogenetic diseases in Brazil: assessing who seeks and who follows through with testing.

Authors:  Caroline Santa Maria Rodrigues; Viviane Ziebell de Oliveira; Gabriela Camargo; Claudio Maria da Silva Osório; Raphael Machado de Castilhos; Maria Luiza Saraiva-Pereira; Lavínia Schuler-Faccini; Laura Bannach Jardim
Journal:  J Genet Couns       Date:  2011-06-30       Impact factor: 2.537

Review 3.  A comprehensive review of spinocerebellar ataxia type 2 in Cuba.

Authors:  Luis Velázquez-Pérez; Roberto Rodríguez-Labrada; Julio Cesar García-Rodríguez; Luis Enrique Almaguer-Mederos; Tania Cruz-Mariño; José Miguel Laffita-Mesa
Journal:  Cerebellum       Date:  2011-06       Impact factor: 3.847

4.  Couples at risk for spinocerebellar ataxia type 2: the Cuban prenatal diagnosis experience.

Authors:  Tania Cruz-Mariño; Luis Velázquez-Pérez; Yanetza González-Zaldivar; Raúl Aguilera-Rodríguez; Miguel Velázquez-Santos; Yaimé Vázquez-Mojena; Annelié Estupiñán-Rodríguez; Rubén Reynaldo-Armiñán; Luis Enrique Almaguer-Mederos; José Miguel Laffita-Mesa; Victor Tamayo-Chiang; Milena Paneque
Journal:  J Community Genet       Date:  2013-05-15

Review 5.  A review of quality of life after predictive testing for and earlier identification of neurodegenerative diseases.

Authors:  Jane S Paulsen; Martha Nance; Ji-In Kim; Noelle E Carlozzi; Peter K Panegyres; Cheryl Erwin; Anita Goh; Elizabeth McCusker; Janet K Williams
Journal:  Prog Neurobiol       Date:  2013-09-11       Impact factor: 11.685

6.  Ethical, social, and cultural issues related to clinical genetic testing and counseling in low- and middle-income countries: a systematic review.

Authors:  Adrina Zhong; Benedict Darren; Bethina Loiseau; Li Qun Betty He; Trillium Chang; Jessica Hill; Helen Dimaras
Journal:  Genet Med       Date:  2018-08-03       Impact factor: 8.822

7.  Social and Cultural Elements Associated with Neurocognitive Dysfunctions in Spinocerebellar Ataxia Type 2 Patients.

Authors:  Roberto Emmanuele Mercadillo; Víctor Galvez; Rosalinda Díaz; Lorena Paredes; Javier Velázquez-Moctezuma; Carlos R Hernandez-Castillo; Juan Fernandez-Ruiz
Journal:  Front Psychiatry       Date:  2015-06-10       Impact factor: 4.157

8.  Genetic counseling and presymptomatic testing programs for Machado-Joseph Disease: lessons from Brazil and Portugal.

Authors:  Lavínia Schuler-Faccini; Claudio Maria Osorio; Flavia Romariz; Milena Paneque; Jorge Sequeiros; Laura Bannach Jardim
Journal:  Genet Mol Biol       Date:  2014-03       Impact factor: 1.771

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.